These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6813024)

  • 1. Apolipoprotein/lipid interactions: studies with synthetic polypeptides.
    Sparrow JT; Gotto AM
    CRC Crit Rev Biochem; 1982; 13(1):87-107. PubMed ID: 6813024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.
    Labeur C; Lins L; Vanloo B; Baert J; Brasseur R; Rosseneu M
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):580-8. PubMed ID: 9102180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipoproteins: apolipoprotein structure and function.
    Mahley RW; Innerarity TL; Rall SC; Weisgraber KH
    J Lipid Res; 1984 Dec; 25(12):1277-94. PubMed ID: 6099394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-binding properties of synthetic peptide fragments of human apolipoprotein A-II.
    Benetollo C; Lambert G; Talussot C; Vanloo E; Cauteren TV; Rouy D; Dubois H; Baert J; Kalopissis A; Denèfle P; Chambaz J; Brasseur R; Rosseneu M
    Eur J Biochem; 1996 Dec; 242(3):657-64. PubMed ID: 9022694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the unique features of HDL apoproteins.
    Pownall HJ; Morrisett JD; Sparrow JT; Smith LC; Shepherd J; Jackson RL; Gotto AM
    Lipids; 1979 Apr; 14(4):428-34. PubMed ID: 220493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A-II: chemical synthesis and biophysical properties of three peptides corresponding to fragments in the amino-terminal half.
    Chen TC; Sparrow JT; Gotto AM; Morrisett JD
    Biochemistry; 1979 Apr; 18(8):1617-22. PubMed ID: 218625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of synthetic peptide fragments of human apolipoprotein A-I with phospholipids.
    Vanloo B; Demoor L; Boutillon C; Lins L; Brasseur R; Baert J; Fruchart JC; Tartar A; Rosseneu M
    J Lipid Res; 1995 Aug; 36(8):1686-96. PubMed ID: 7595090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipid binding studies with synthetic apolipoprotein fragments.
    Sparrow JT; Gotto AM
    Ann N Y Acad Sci; 1980; 348():187-211. PubMed ID: 6772077
    [No Abstract]   [Full Text] [Related]  

  • 9. Apolipoprotein C-II39-62 activates lipoprotein lipase by direct lipid-independent binding.
    MacPhee CE; Hatters DM; Sawyer WH; Howlett GJ
    Biochemistry; 2000 Mar; 39(12):3433-40. PubMed ID: 10727238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic model peptides for apolipoproteins. I. Design and properties of synthetic model peptides for the amphipathic helices of the plasma apolipoproteins.
    Brasseur R; Vanloo B; Deleys R; Lins L; Labeur C; Taveirne J; Ruysschaert JM; Rosseneu M
    Biochim Biophys Acta; 1993 Sep; 1170(1):1-7. PubMed ID: 8399322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of a biologically active fragment of human serum apolipoprotein C-II in the presence of sodium dodecyl sulfate and dodecylphosphocholine.
    Storjohann R; Rozek A; Sparrow JT; Cushley RJ
    Biochim Biophys Acta; 2000 Jul; 1486(2-3):253-64. PubMed ID: 10903476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.
    Mendez AJ; Anantharamaiah GM; Segrest JP; Oram JF
    J Clin Invest; 1994 Oct; 94(4):1698-705. PubMed ID: 7929849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional properties of the 154-171 wild-type and variant peptides of human lecithin-cholesterol acyltransferase.
    Peelman F; Goethals M; Vanloo B; Labeur C; Brasseur R; Vandekerckhove J; Rosseneu M
    Eur J Biochem; 1997 Nov; 249(3):708-15. PubMed ID: 9395317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformation of human apolipoprotein C-I in a lipid-mimetic environment determined by CD and NMR spectroscopy.
    Rozek A; Sparrow JT; Weisgraber KH; Cushley RJ
    Biochemistry; 1999 Nov; 38(44):14475-84. PubMed ID: 10545169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.
    Yamamoto M; Morita SY; Kumon M; Kawabe M; Nishitsuji K; Saito H; Vertut-Doï A; Nakano M; Handa T
    Biochim Biophys Acta; 2003 Jun; 1632(1-3):31-9. PubMed ID: 12782148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein and lipid abnormalities in uremic children on hemodialysis.
    Ohta T; Matsuda I
    Clin Chim Acta; 1985 Apr; 147(2):145-54. PubMed ID: 3921292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of virus-induced cell fusion by apolipoprotein A-I and its amphipathic peptide analogs.
    Srinivas RV; Venkatachalapathi YV; Rui Z; Owens RJ; Gupta KB; Srinivas SK; Anantharamaiah GM; Segrest JP; Compans RW
    J Cell Biochem; 1991 Feb; 45(2):224-37. PubMed ID: 1647394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a model class A (apolipoprotein) amphipathic alpha helical peptide with lipid: high resolution NMR studies of peptide.lipid discoidal complexes.
    Mishra VK; Anantharamaiah GM; Segrest JP; Palgunachari MN; Chaddha M; Sham SW; Krishna NR
    J Biol Chem; 2006 Mar; 281(10):6511-9. PubMed ID: 16407255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helix-helix association of a lipid-bound amphipathic alpha-helix derived from apolipoprotein C-II.
    MacPhee CE; Howlett GJ; Sawyer WH; Clayton AH
    Biochemistry; 1999 Aug; 38(33):10878-84. PubMed ID: 10451384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.